tradingkey.logo

IDEXX实验室

IDXX
676.710USD
-11.030-1.60%
收盘 01/29, 16:00美东报价延迟15分钟
54.14B总市值
53.26市盈率 TTM

IDEXX实验室

676.710
-11.030-1.60%

关于 IDEXX实验室 公司

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX实验室简介

公司代码IDXX
公司名称IDEXX Laboratories Inc
上市日期Jun 21, 1991
CEOEmerson (Andrew)
员工数量11000
证券类型Ordinary Share
年结日Jun 21
公司地址One Idexx Drive
城市WESTBROOK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编04092-2041
电话12075560300
网址https://www.idexx.com/
公司代码IDXX
上市日期Jun 21, 1991
CEOEmerson (Andrew)

IDEXX实验室公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+262.00%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+346.00%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+183.00%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+1447.00%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+262.00%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+1018.00%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+262.00%
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+262.00%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+346.00%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+183.00%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+1447.00%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+262.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
CAG Diagnostics recurring revenue
873.27M
79.01%
IDEXX VetLab consumables
387.81M
35.09%
Reference laboratory diagnostic and consulting services
362.73M
32.82%
Rapid assay products
88.64M
8.02%
CAG Diagnostics capital - instruments
87.78M
7.94%
其他
-694.99M
-62.88%
地区USD
名称
营收
占比
United States
705.04M
63.79%
Europe & Middle East & Africa (EMEA) (Region)
245.06M
22.17%
Asia Pacific
90.72M
8.21%
Canada
41.38M
3.74%
Latin America
23.04M
2.08%
业务
地区
业务USD
名称
营收
占比
CAG Diagnostics recurring revenue
873.27M
79.01%
IDEXX VetLab consumables
387.81M
35.09%
Reference laboratory diagnostic and consulting services
362.73M
32.82%
Rapid assay products
88.64M
8.02%
CAG Diagnostics capital - instruments
87.78M
7.94%
其他
-694.99M
-62.88%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.41%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
其他
70.23%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.41%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
3.13%
其他
70.23%
股东类型
持股股东
占比
Investment Advisor
53.99%
Investment Advisor/Hedge Fund
30.94%
Research Firm
3.98%
Pension Fund
2.91%
Bank and Trust
1.86%
Individual Investor
0.69%
Sovereign Wealth Fund
0.59%
Hedge Fund
0.54%
Family Office
0.50%
其他
4.01%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
2344
75.90M
95.05%
-6.23M
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
9.93M
12.43%
+85.73K
+0.87%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.24M
6.56%
-65.11K
-1.23%
Sep 30, 2025
State Street Investment Management (US)
3.52M
4.41%
-36.75K
-1.03%
Sep 30, 2025
Fundsmith LLP
2.61M
3.27%
-28.83K
-1.09%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.50M
3.13%
+33.39K
+1.35%
Sep 30, 2025
Baron Capital Management, Inc.
1.88M
2.36%
-148.49K
-7.31%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
1.79M
2.24%
+114.65K
+6.84%
Dec 31, 2025
Principal Global Investors (Equity)
1.32M
1.65%
+187.97K
+16.67%
Sep 30, 2025
Polen Capital Management, LLC
1.13M
1.41%
-68.28K
-5.71%
Sep 30, 2025
Walter Scott & Partners Ltd.
1.12M
1.4%
+360.23K
+47.61%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
查看更多
ProShares Pet Care ETF
占比9.4%
iShares U.S. Medical Devices ETF
占比4.42%
First Trust Water ETF
占比3.98%
SMI 3Fourteen Full-Cycle Trend ETF
占比3.9%
Nuveen ESG Mid-Cap Growth ETF
占比3.47%
Adaptive Core ETF
占比2.61%
First Trust S&P 500 Economic Moat Index ETF
占比2.25%
Acruence Active Hedge US Equity ETF
占比2.18%
Tema Durable Quality ETF
占比2.1%
Putnam Sustainable Future ETF
占比2.03%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI